OgilvyHealthPR appoints Wendy Gerber and Tania Kouprach-Rolandi

pharmafile | January 24, 2011 | Appointment | Medical Communications OgilvyHealthPR, Tania Kouprach-Rolandi, Wendy Gerber, appointment, medical communications 

OgilvyHealthPR has strengthened its London team with the appointments of Wendy Gerber and Tania Kouprach-Rolandi, who will focus on HIV, and cardiology and oncology respectively.

Wendy (pictured) joins OHPR as an associate director having previously worked at WCG, MS&L and Chameleon Communications International.

She has degrees from University of Texas and University of California and was a senior postdoctoral research fellow at the Max Planck Institute for Biophysical Chemistry in Göttingen, Germany for four years.

Advertisement

Tania joins as a senior account manager from Athena Medical Communications where she worked across global and UK accounts in categories including mental health, cardiovascular disease, hospital devices and oncology.

A trained pharmacist, Tania worked as a hospital pharmacist for four years prior to her move into medical communications.

“Both Wendy and Tania bring scientific expertise and communications experience that will benefit our clients,” said Ogilvy Health PR managing director, Antonia Betts.

“Additionally, with collective experience of having worked on three continents (North America, Australia & Europe), they strengthen OHPR’s already diverse international offer.”

Related Content

Men’s health – a new report from the Department of Health and Social Care

The UK Department of Health and Social Care has published a new report entitled Men’s …

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025

The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

David Wheadon appointed to board of directors at Seaport Therapeutics

This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

The Gateway to Local Adoption Series

Latest content